Correction to: Tertiary Care Experience of Sorafenib in the Treatment of Progressive Radioiodine-Refractory Differentiated Thyroid Carcinoma: A Korean Multicenter Study , by Kim M, Kim TH, Shin DY, Lim DJ, Kim EY, Kim WB, Chung JH, Shong YK, Kim BH,

首页> 外文期刊>Thyroid: official journal of the American Thyroid Association >Correction to: Tertiary Care Experience of Sorafenib in the Treatment of Progressive Radioiodine-Refractory Differentiated Thyroid Carcinoma: A Korean Multicenter Study , by Kim M, Kim TH, Shin DY, Lim DJ, Kim EY, Kim WB, Chung JH, Shong YK, Kim BH,

【24h】

Correction to: Tertiary Care Experience of Sorafenib in the Treatment of Progressive Radioiodine-Refractory Differentiated Thyroid Carcinoma: A Korean Multicenter Study , by Kim M, Kim TH, Shin DY, Lim DJ, Kim EY, Kim WB, Chung JH, Shong YK, Kim BH,

机译：矫正：Sorafenib的第三级护理经验治疗渐进式放射性碘 - 难以分化的甲状腺癌：韩国多中心研究，由Kim M，Kim Th，Shin Dy，Lim Dj，Kim Ey，Kim WB，Chung Jh，Shong Yk kim bh，

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

"Correction to: Tertiary Care Experience of Sorafenib in the Treatment of Progressive Radioiodine-Refractory Differentiated Thyroid Carcinoma: A Korean Multicenter Study, by Kim M, Kim TH, Shin DY, Lim DJ, Kim EY, Kim WB, Chung JH, Shong YK, Kim BH, and Kim WG on behalf of Korean Thyroid Cancer Study Group (KTCSG).Thyroid 2018;28(3)340–348. DOI: 10.1089/thy.2017.0356." Thyroid , 28(5), p. 686.

机译：“矫正：索拉酮的第三级护理经验治疗渐进式放射性碘 - 难治性分化甲状腺癌：韩国多中心研究，由Kim M，Kim Th，Shin Dy，Lim Dj，Kim Ey，Kim WB，Chung Jh，Zhong Yk ，Kim BH和Kim WG代表韩国甲状腺癌研究组（KTCSG）.Thyroid 2018; 28（3）340-348。DOI：10.1089 / Thy.2017.0356。“ 甲状腺，28（5），p。 686。

著录项

来源
《Thyroid: official journal of the American Thyroid Association》 |2018年第5期|共1页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类内分泌腺疾病及代谢病;
关键词

相似文献

外文文献

1. Correction to: Tertiary Care Experience of Sorafenib in the Treatment of Progressive Radioiodine-Refractory Differentiated Thyroid Carcinoma: A Korean Multicenter Study , by Kim M, Kim TH, Shin DY, Lim DJ, Kim EY, Kim WB, Chung JH, Shong YK, Kim BH, [J] . Thyroid: official journal of the American Thyroid Association . 2018,第5期

机译：矫正：Sorafenib的第三级护理经验治疗渐进式放射性碘 - 难以分化的甲状腺癌：韩国多中心研究，由Kim M，Kim Th，Shin Dy，Lim Dj，Kim Ey，Kim WB，Chung Jh，Shong Yk kim bh，
2. Tertiary Care Experience of Sorafenib in the Treatment of Progressive Radioiodine-Refractory Differentiated Thyroid Carcinoma: A Korean Multicenter Study [J] . Kim Mijin, Kim Tae Hyuk, Shin Dong Yeob, Thyroid: official journal of the American Thyroid Association . 2018,第3期

机译：Sorafenib治疗渐进式放射性碘 - 难治差异化甲状腺癌的第三级护理体验：韩国多中心研究
3. Correction to: Tertiary Care Experience of Sorafenib in the Treatment of Progressive Radioiodine-Refractory Differentiated Thyroid Carcinoma: A Korean Multicenter Study by Kim M Kim TH Shin DY Lim DJ Kim EY Kim WB Chung JH Shong YK Kim BH and Kim WG on behalf of Korean Thyroid Cancer Study Group (KTCSG).Thyroid 2018;28(3)340–348. DOI: 10.1089/thy.2017.0356 [O] . -1

机译：校正至：索拉非尼在进行性放射性碘难治性分化型甲状腺癌治疗中的三级护理经验：一项韩国多中心研究作者：Kim MKim THShin DYLim DJKim EYKim WBChung JHShong YK Kim BH和Kim WG代表韩国甲状腺癌研究小组（KTCSG）。甲状腺2018; 28（3）340–348。 DOI：10.1089 / thy.2017.0356
4. Tertiary Care Experience of Sorafenib in the Treatment of Progressive Radioiodine-Refractory Differentiated Thyroid Carcinoma: A Korean Multicenter Study [O] . Mijin Kim, Tae Hyuk Kim, Dong Yeob Shin, 2018

机译：Sorafenib在渐进式放射性碘 - 难治差异化甲状腺癌中的三级护理体验：韩国多中心研究

Correction to: Tertiary Care Experience of Sorafenib in the Treatment of Progressive Radioiodine-Refractory Differentiated Thyroid Carcinoma: A Korean Multicenter Study , by Kim M, Kim TH, Shin DY, Lim DJ, Kim EY, Kim WB, Chung JH, Shong YK, Kim BH,

摘要

著录项

相似文献

相关主题

期刊订阅